Skip to main content
Valneva SE logo

Valneva SE — Investor Relations & Filings

Ticker · VLA ISIN · FR0004056851 LEI · 969500DIVIP5VKNW4948 PA Manufacturing
Open in API
Filings indexed 1,670 across all filing types
Latest filing 2026-06-05 Regulatory Filings
Country FR France
Listing PA VLA

About Valneva SE

https://valneva.com/

Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet medical needs. The company has leveraged its expertise to commercialize three vaccines, including a single-shot vaccine for chikungunya. Its research and development pipeline features a broad range of vaccine candidates, including those targeting Lyme disease, Shigella, and Zika.

Recent filings

Filing Released Lang Actions
6-K
Regulatory Filings Classification · 90% confidence The document is a SEC Form 6-K by Valneva SE reporting a press release (Exhibit 99.1) dated June 4, 2026. It does not contain substantive financial statements or management discussion; it merely incorporates a press release by reference. Under the classification definitions, a Form 6-K is a general regulatory submission by a foreign issuer. It therefore falls under the fallback category for miscellaneous regulatory filings (RNS).
2026-06-05 English
Valneva annonce la mise à disposition de la documentation relative à son Assemblée Générale annuelle
Report Publication Announcement Classification · 92% confidence The document is a press release by Valneva SE announcing the availability (“mise à disposition”) of documentation related to its upcoming Annual General Meeting (convening notice, agenda, draft resolutions, voting instructions). It does not contain the AGM materials themselves nor any vote results or financial statements. Instead, it simply informs shareholders how and where to access the preparatory documents. This matches the definition of a Report Publication Announcement (RPA).
2026-06-04 French
Valneva Announces Availability of Documentation for its Annual General Meeting
Regulatory Filings
2026-06-04 English
VALNEVA : Déclaration d’actions et de droits de vote - Statut au 31 mai 2026
Regulatory Filings Classification · 75% confidence The document is a French regulatory declaration (‘Déclaration d’actions et de droits de vote’) showing the number of shares and voting rights as of May 31, 2026. It is neither an AGM result (no vote outcomes), nor a threshold-crossing major shareholding notice, nor a financial report, presentation or capital change event. This type of mandatory AMF compliance filing does not match any more specific category, so by rule it falls under General Regulatory Filings (RNS).
2026-06-03 French
VALNEVA:Declaration of shares and voting rights - Status as of May 31, 2026
Regulatory Filings Classification · 85% confidence The document is a periodic declaration of the company’s share capital and total voting rights as of a given date (May 31, 2026), published in accordance with AMF regulations. It is not an AGM voting result, earnings release, nor a management discussion; it is a standard regulatory announcement that does not fit any more specific category and thus falls under Regulatory Filings (RNS).
2026-06-03 English
6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K “Report of Foreign Private Issuer” under the U.S. Securities Exchange Act, simply attaching a press release as Exhibit 99.1. It does not itself contain substantive financial statements or annual/quarterly report content, nor is it a management discussion or earnings release but rather a regulatory filing under SEC rules. This aligns with the “Regulatory Filings (RNS)” category as a catch-all for miscellaneous SEC filings not covered by more specific report types.
2026-06-01 English

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.